p21iPSC线CRISPR-Cas9

Yi-Dan Sun1,2, Guo-Hua Li1,2, Feng Zhang1,2

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, People's Republic of China.

Stem cells (Dayton, Ohio)
|September 16, 2024
PubMed
概括

一个新的记者细胞系在CRISPR-Cas9基因编辑后跟踪TP53-p21通路激活. 该工具有助于选导向RNA并评估载体安全性,发现对敏感细胞更安全的lentiviral载体.